CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

What happened: CRISPR Therapeutics AG (CRSP) closed down 5.82% at $54.00, trailing a session where the S&P 500 rose 0.58%, the Dow rose 0.49%, and the Nasdaq rose 0.45%. Key numbers: CRSP $54.00, down 5.82%. Up 2.78% over the past month. Projected quarterly EPS -$1.06, revenue $9.53 million. Annual estimates: EPS -$4.47, revenue $30.59 million. Why it matters: The stock fell while major indexes gained. Upcoming earnings are expected to show EPS growth and a large revenue rise versus the year-ago quarter, and analysts' estimate revisions are cited as a driver of near-term performance.

CRISPR Therapeutics AG (CRSP) closed down 5.82% at $54.00, trailing a session where the S&P 500 rose 0.58%, the Dow rose 0.49%, and the Nasdaq rose 0.45%.

The stock fell while major indexes gained. Upcoming earnings are expected to show EPS growth and a large revenue rise versus the year-ago quarter, and analysts' estimate revisions are cited as a driver of near-term performance.